http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2870966-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88123155ca8a10bccbe8ca81c45812e2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-603
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-603
filingDate 2013-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b9ec58d2254e81ccd204cb996cb0226
publicationDate 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2870966-A1
titleOfInvention Salicylates for use in the treatment of cancer
abstract The present invention relates to a dosage regimen of salicylates (ASA/diflunisal combined with at least two different salicylates selected from ASA/ 4-aminosalicylic acid and diflunisal) for use in the treatment of cancer.
priorityDate 2013-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5985927-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005016354-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9858639-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9630003-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413484
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID91404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226791052
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID444013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44153517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID228071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118057953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID311474868

Total number of triples: 46.